ESMO Guidelines: Real World Cases Webinar – Bladder Cancer
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society
An evidence-based and patient-centred approach to close the care gap for a healthier Europe
The abstract submission will open soon
Abstract submission is now open!
His research interests focus on clinical and basic research in sarcomas, targeted treatment of cancer, the biology of breast carcinoma…
The aim of this web section is to transform learning on lymphomas into an easy and enjoyable experience by using a very visual and didactic…
An evidence-based and patient-centred approach to close the care gap for a healthier Europe
ESMO’s mobile app: “ESMO Cancer Guidelines” features six titles each one providing the essential recommendations on a specific topic.
High rates of adverse events in the experimental setting seem to limit the potential of antibody–drug conjugates for patients with NSCLC
ctDNA offers immense possibilities for improving the management of early-stage lung cancer